Design and Evaluation of the living lab to assess vCare system “virtual coaching activities for rehabilitation in elderly” in Parkinson´s disease patients
Objective: To evaluate the Living Lab phase from the European Project vCare (Virtual Coaching Activities for Rehabilitation in Elderly) and the satisfaction level with vCare…Shank range of motion as a measure of gait impairment in TUG test
Objective: The purpose of this study is to evaluate the efficacy of a gyroscope-based estimation of shank range of motion (RoM) as a measure to…Smartphone-based mobility assessment in Parkinson’s disease: A validity study
Objective: To create and test a smartphone application that enables self-administration of Timed-up-and-go (TUG) test, under both normal and dual-task conditions. Background: The TUG test…The online MDS educational resources helped young neurologists maintain their training during the Covid-19 pandemic
Objective: To analyse the impact of the COVID-19 pandemic on the young MDS members assessing their satisfaction with the MDS virtual educational tools. Background: The…Is past use of statins associated with lower incidence of Parkinson’s disease?
Objective: To examine the relation of past exposure to statins with Parkinson’s disease (PD) incidence. Background: Drug repurposing has recently emerged as a promising approach…“I’ve got cataracts and can’t read the information sheet about the medication you have given me”*
Objective: This study reports People with Parkinson’s (PWP) perception on their illness, its meaning to them and their view of the interactions they have with…Identifying and Controlling Variability in Digital Health Measures in Parkinson’s disease Clinical Trials
Objective: The 3DT initiative of the Critical Path for Parkinson’s Consortium (CPP) aims to advance the regulatory maturity of digital biomarkers, for clinical studies in…Impact of 3-month earlier versus postponed initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson’s disease and motor fluctuations
Objective: This post-hoc analysis evaluated the impact of 3-month earlier versus postponed initiation of opicapone (OPC) in patients with Parkinson’s disease (PD) and motor fluctuations.…Effects of Opicapone on Sleep in Patients with Parkinson’s Disease and Motor Fluctuations
Objective: To assess the effects of opicapone (OPC: 50 mg, once-daily) on sleep in patients with Parkinson’s disease (PD) and motor fluctuations. Background: OPC is…A new fully implantable Adaptive Deep Brain Stimulation system tested for the first time in patients with Parkinson’s Disease
Objective: This multicenter double-blind crossover study has been designed to evaluate the safety and efficacy of adaptive Deep Brain Stimulation delivered through an innovative IPG…
- « Previous Page
- 1
- …
- 307
- 308
- 309
- 310
- 311
- …
- 338
- Next Page »